Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
At Advantage Living Center in Roseville, Michigan, Janelle prepares medication for a resident Photograph by Ali Lapetina
Letter |
14 April 2021

Letter from civil society organisations to US President Biden on TRIPS Waiver for COVID-19 medical tools

COVID-19
COVID19_Letter_TRIPSWaiverSignOnLetter_ENG_022621
Photograph by Ali Lapetina

Read, watch, share

An MSF Health Promoter speaks with people about how to keep safe during the COVID-19 pandemic.
Letter
Letter |
19 May 2020
Intellectual property and trade
South Africa

South Africa’s patent laws threaten access to future COVID-19 medicines

Statement |
18 May 2020
COVID-19

MSF and DNDi joint statement at WHA73: COVID-19 response

Letter |
18 May 2020
COVID-19

COVID-19 – CSO open letter to UNITAID, the World Health Organization (WHO) and its Member States

MSF Logistician Eric Schimdt prepares dozens of cellphones for distribution. MSF’s COVID-19 team in New York City is distributing 1,000 cellphones to people who are currently homeless and housing insecure so they can contact emergency, medical and social services.
Letter
Letter |
16 May 2020
COVID-19

WHO and Unitaid must ensure binding commitments for equitable access to COVID-19 technologies

World Health Assembly Photo by WHO
Events
Events |
15 May 2020
COVID-19

MSF at the 73rd World Health Assembly

1 min
Technical brief |
13 May 2020
COVID-19

MSF Access Campaign position paper on the sharing of technologies for COVID-19 to ensure equitable access for all

TB and HIV patients in Eswatini in a context of COVID-19
Video
Video |
09 May 2020
COVID-19
Eswatini

Eswatini: responding to COVID-19 in a setting with high rates of HIV and TB

1 min
MSF medical team in Matsenjeni health centre Photograph by Jakub Hein
Feature story
Feature story |
09 May 2020
COVID-19
Eswatini

Eswatini: Responding to COVID-19 in a country already fighting a dual HIV/TB epidemic

9 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury